PERKINS CAPITAL MANAGEMENT INC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
PERKINS CAPITAL MANAGEMENT INC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$534
+7.9%
9,1910.0%0.53%
+22.7%
Q2 2023$495
+46.0%
9,191
+7.8%
0.43%
+34.7%
Q1 2023$339
-1.2%
8,5260.0%0.32%
-11.6%
Q4 2022$343
-99.9%
8,5260.0%0.36%
+17.9%
Q3 2022$274,000
-2.1%
8,526
-9.5%
0.31%
+5.9%
Q2 2022$280,000
+5.7%
9,4260.0%0.29%
+33.6%
Q1 2022$265,000
-47.3%
9,426
-13.7%
0.22%
-36.2%
Q4 2021$503,000
+8.9%
10,926
-22.4%
0.34%
+18.9%
Q3 2021$462,000
-6.3%
14,0760.0%0.29%
+2.1%
Q2 2021$493,000
-7.0%
14,076
-4.0%
0.28%
-8.5%
Q1 2021$530,000
-25.2%
14,666
+27.6%
0.31%
-51.9%
Q4 2019$709,000
-57.3%
11,491
-49.6%
0.64%
-55.5%
Q3 2019$1,660,000
-32.2%
22,783
-23.5%
1.43%
-16.7%
Q2 2019$2,450,000
+6.7%
29,800
-8.4%
1.72%
+13.5%
Q1 2019$2,296,000
+56.0%
32,550
-0.5%
1.51%
+32.5%
Q4 2018$1,472,000
-21.0%
32,700
-0.8%
1.14%
+2.1%
Q3 2018$1,863,000
-10.0%
32,950
+6.3%
1.12%
-24.6%
Q2 2018$2,071,000
+31.7%
31,000
+14.8%
1.48%
+4.8%
Q1 2018$1,572,000
-9.7%
27,0000.0%1.42%
-15.4%
Q4 2017$1,740,000
+67.5%
27,000
+36.4%
1.67%
+53.6%
Q3 2017$1,039,000
+3.0%
19,800
-8.1%
1.09%
-2.7%
Q2 2017$1,009,000
-8.0%
21,550
-2.7%
1.12%
-1.1%
Q1 2017$1,097,00022,1501.13%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders